CAP 150 (Capecitabine 150 mg)
Pill with imprint CAP 150 is Pink, Capsule-shape and has been identified as Capecitabine 150 mg. It is supplied by Shilpa Medicare Limited.
Capecitabine is used in the treatment of colorectal cancer; breast cancer, metastatic; breast cancer; non-small cell lung cancer; pancreatic cancer (and more), and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Capecitabine 150 mg is not a controlled substance under the Controlled Substance Act (CSA).
Images for CAP 150
Capecitabine
- Imprint:
- CAP 150
- Strength:
- 150 mg
- Color:
- Pink
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Antimetabolites
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Shilpa Medicare Limited
- National Drug Code (NDC):
- 63759-3000
More about capecitabine
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 24 Reviews – Add your own review/rating
- Drug class: antimetabolites
Consumer resources
Other brands: Xeloda
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
